Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
BMC Pregnancy Childbirth ; 22(1): 142, 2022 Feb 21.
Article in English | MEDLINE | ID: covidwho-1706234


BACKGROUND: Thrombotic microangiopathy has been invoked as one of the most important mechanisms of damage in COVID-19 patients. Protease ADAMTS13 is a marker of microangiopathy responsible for controlling von Willebrand multimers size. Von Willebrand factor/ADAMTS13 ratio has been found impaired in COVID-19 patients outside pregnancy. METHODS: We prospectively investigated 90 pregnant women admitted to two tertiary academic hospitals in Italy with a laboratory-confirmed diagnosis of SARS-CoV-2 infection. Demographic, clinical information and routine laboratory data were collected at the hospital admission and until discharge. We investigated whether vonWillebrand /ADAMTS13 axis imbalance is a predictor of adverse outcomes. Logistic regression analysis, which controlled for potential confounders, was performed to evaluate the association between laboratory parameters and clinical outcomes. RESULTS: Most women (55.6%) were parae, with median gestational age at admission of 39 weeks. At hospital admission, 63.3% were asymptomatic for COVID-19 and 24.4% showed more than one sign or symptom of infection. Nulliparae with group O showed Willebrand / ADA MTS-13 ratios significantly lower than non-O, whereas in multiparae this difference was not observed. Logistic regression showed that ratio von Willebrand to ADAMTS13 was significantly and independently associated with preterm delivery (OR 1.9, 95%CI 1.1-3.5). CONCLUSION: This study shows an imbalance of vonWillebrand /ADAMTS13 axis in pregnant women with COVID-19, leading to a significantly higher and independent risk of preterm delivery. Monitoring these biomarkers might support decision making process to manage and follow-up pregnancies in this setting.

ADAMTS13 Protein/blood , COVID-19/blood , Pregnancy Complications/blood , Premature Birth/blood , von Willebrand Factor/metabolism , Academic Medical Centers , Adolescent , Adult , Biomarkers/blood , COVID-19/complications , Female , Humans , Italy/epidemiology , Middle Aged , Pregnancy , SARS-CoV-2 , Tertiary Care Centers , Thrombotic Microangiopathies/etiology , Young Adult